Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Respirology - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
Naomi Rodrig, one year ago
Third-generation EGFR tyrosine kinase inhibitors (TKIs) designed to overcome the T790M mutation have been shown to double progression-free survival (PFS) of patients with advanced non-small-cell lung cancer (NSCLC) harbouring activating EGFR mutations, according to reports at the European Lung Cancer Conference (ELCC) 2016 held recently in Geneva, Switzerland.
Joy Wee, one year ago
Symptomatic rhinovirus (RV) infections in infants are associated with a decrease in bacterial diversity and higher bacterial density of the respiratory microbiota.
one year ago
Umeclidinium/vilanterol improves SGRQ total score and decreased rescue albuterol use in patients with chronic obstructive pulmonary disease (COPD), as observed in a 12-week multicentre, randomised, double-blind, parallel-group, placebo-controlled study.
one year ago
Fluticasone furoate-vilanterol combination increases trough forced expiratory volume in 1 second compared with fluticasone furoate-fluticasone propionate in patients with symptomatic asthma, as stated in a systemic review with meta-analysis of seven published randomised clinical trials.